InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Stian Kildal, Chief Executive Officer. Officer active across 1 company, notably OncoZenge AB. Aggregated, 4 filings have been published. History available since 28 March 2025. The latest transaction was disclosed on 6 September 2026 (Purchase). Regulator: FIN-FSA. The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Stian Kildal is the CEO of OncoZenge AB. He is responsible for the strategic direction and daily management of the company. With experience in the biotechnology field, Stian strives to promote innovation and growth within OncoZenge AB.